Evidence map›Paper›PMID 26040537›Full record

ArticlePsychological medicine2015

Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective.

C M Corcoran, J G Keilp, J Kayser, C Klim, P D Butler, G E Bruder, R C Gur, D C Javitt

Abstract read
In one paragraph

Article in Psychological medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 2 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 2 syntheses or guidelines pooled it, 137 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

C M CorcoranDepartment of Psychiatry,Columbia University,New York,NY,USA.
J G KeilpDepartment of Psychiatry,Columbia University,New York,NY,USA.
J KayserDepartment of Psychiatry,Columbia University,New York,NY,USA.
C KlimDepartment of Psychiatry,Columbia University,New York,NY,USA.
P D ButlerNathan Kline Institute for Psychiatric Research,Orangeburg,NY,USA.
G E BruderDepartment of Psychiatry,Columbia University,New York,NY,USA.
R C GurDepartment of Psychiatry,University of Pennsylvania,Philadelphia,PA,USA.
D C JavittDepartment of Psychiatry,Columbia University,New York,NY,USA.
Columbia University · USNathan Kline Institute for Psychiatric Research · USNew York University · USUniversity of Pennsylvania · US

Funding

Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
The Conte Center for Schizophrenia ResearchP50MH086385 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JAVITT, DANIEL C. · 2009 to 2013
$10.7M
Olfaction in the Psychosis Prodrome: Behavioral and ERP MeasuresR21MH086125 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI BRUDER, GERARD E, CORCORAN, CHERYL MARY · 2009 to 2010
$440k
NCATS NIH HHS UL1 TR000040NIMH NIH HHS P50 MH086385NIMH NIH HHS R01P50MH086384NIMH NIH HHS R01P50MH086384 S1NIMH NIH HHS R21 MH086125NIMH NIH HHS R21MH086125
6 · The paper itself

Abstract

backgroundSchizophrenia is characterized by profound and disabling deficits in the ability to recognize emotion in facial expression and tone of voice. Although these deficits are well documented in established schizophrenia using recently validated tasks, their predictive utility in at-risk populations has not been formally evaluated.

methodThe Penn Emotion Recognition and Discrimination tasks, and recently developed measures of auditory emotion recognition, were administered to 49 clinical high-risk subjects prospectively followed for 2 years for schizophrenia outcome, and 31 healthy controls, and a developmental cohort of 43 individuals aged 7-26 years. Deficit in emotion recognition in at-risk subjects was compared with deficit in established schizophrenia, and with normal neurocognitive growth curves from childhood to early adulthood.

resultsDeficits in emotion recognition significantly distinguished at-risk patients who transitioned to schizophrenia. By contrast, more general neurocognitive measures, such as attention vigilance or processing speed, were non-predictive. The best classification model for schizophrenia onset included both face emotion processing and negative symptoms, with accuracy of 96%, and area under the receiver-operating characteristic curve of 0.99. In a parallel developmental study, emotion recognition abilities were found to reach maturity prior to traditional age of risk for schizophrenia, suggesting they may serve as objective markers of early developmental insult.

conclusionsProfound deficits in emotion recognition exist in at-risk patients prior to schizophrenia onset. They may serve as an index of early developmental insult, and represent an effective target for early identification and remediation. Future studies investigating emotion recognition deficits at both mechanistic and predictive levels are strongly encouraged.

Indexed as

Discrimination, PsychologicalEmotionsFacial ExpressionRecognition, PsychologyAdolescentAdultCase-Control StudiesChildFemaleHumansMaleNeuropsychological TestsPrognosisPsychiatric Status Rating ScalesSchizophreniaYoung AdultAuditory processingface processingprodromepsychosis

Identifiers

PMID26040537
PMCPMC5080982
OpenAlexW2278262299

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.